A Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability and Pharmacokinetics of AVLX-144

Clinical trial NCT04689035 · COMPLETED

Trial details

NCT number: NCT04689035
Sponsor: Avilex Pharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Safety Issues Tolerance

Start date: 2020-09-27
Primary completion: 2023-07-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.